Email this article Vozmozhnosti predotvrashcheniya serdechno-sosudistykh oslozhneniyu patsientov s vysokim riskom: rezul'taty issledovaniya TRANSCEND
- Authors: Chazova IE1, Ratova LG1
-
Affiliations:
- Issue: Vol 5, No 4 (2008)
- Pages: 4-7
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/28818
- DOI: https://doi.org/10.26442/SG28818
- ID: 28818
Cite item
Full Text
Abstract
References
- Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.
- ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358 (15): 1547-59.
- TRANSCEND Investigators, Yusuf S, Teo K, Anderson C et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008; 372 (9644): 1174-83.
Supplementary files
